These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 20370577)
1. IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription. Mireuta M; Darnel A; Pollak M Growth Factors; 2010 Aug; 28(4):243-55. PubMed ID: 20370577 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes. Wilhelm F; Kässner F; Schmid G; Kratzsch J; Laner A; Wabitsch M; Körner A; Kiess W; Garten A Growth Horm IGF Res; 2015 Jun; 25(3):115-20. PubMed ID: 25900365 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells. Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485 [TBL] [Abstract][Full Text] [Related]
4. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Martin JL; Baxter RC Endocrinology; 2007 May; 148(5):2532-41. PubMed ID: 17289850 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Conover CA; Bale LK; Durham SK; Powell DR Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879 [TBL] [Abstract][Full Text] [Related]
9. Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway. Li Z; Miard S; Laplante M; Sonenberg N; Picard F Mol Cell Endocrinol; 2012 Jul; 358(1):63-8. PubMed ID: 22410287 [TBL] [Abstract][Full Text] [Related]
10. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K-Akt-mTOR signal pathway dismissed the stimulation of glucose on goose liver cell growth. Wei S; Han C; He F; Song Q; Kang B; Liu H; Li L; Xu H; Zeng X J Anim Physiol Anim Nutr (Berl); 2017 Oct; 101(5):e133-e143. PubMed ID: 27859698 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765 [TBL] [Abstract][Full Text] [Related]
13. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. Sun DF; Fang JY; Zhang YJ; Tian XQ; Zhu HY; Li EL; Gu WQ; Shen GF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526 [TBL] [Abstract][Full Text] [Related]
14. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins. Mounier C; Dumas V; Posner BI Endocrinology; 2006 May; 147(5):2383-91. PubMed ID: 16455781 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321 [TBL] [Abstract][Full Text] [Related]
17. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
19. Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Yin P; Zhao C; Li Z; Mei C; Yao W; Liu Y; Li N; Qi J; Wang L; Shi Y; Qiu S; Fan J; Zha X Cell Signal; 2012 Jun; 24(6):1229-40. PubMed ID: 22360859 [TBL] [Abstract][Full Text] [Related]
20. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1. Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]